Curative criteria for endoscopic treatment of oesophageal squamous cell cancer

Best Pract Res Clin Gastroenterol. 2024 Feb:68:101894. doi: 10.1016/j.bpg.2024.101894. Epub 2024 Feb 17.

Abstract

Endoscopic treatment of early oesophageal squamous cell carcinoma is widely accepted. ESD (Endoscopic Submucosal Dissection), which allows en bloc resection regardless of size, provides resected specimens that facilitate histological evaluation of curability. In the histological investigation, the determination of tumor depth, lymphovascular involvement, and lateral and vertical margins play a great role in the assessment of curability. The diagnosis of lymphovascular invasion, in particular, is enhanced by the addition of immunostaining. The long-term outcome of ESD is comparable to that of oesophagectomy, and ESD may be the first-line treatment for early-stage oesophageal cancer due to its fewer complications. Surveillance after curative resection is also imperative because oesophageal cancer is often characterized by the concept of field cancerization, which results in metachronous multiple primary lesions.

Keywords: Curative resection; Endoscopic submucosal dissection; Superficial oesophageal squamous cell cancer; Surveillance.

Publication types

  • Review

MeSH terms

  • Endoscopic Mucosal Resection* / methods
  • Endoscopy
  • Epithelial Cells / pathology
  • Esophageal Neoplasms* / pathology
  • Esophageal Neoplasms* / surgery
  • Esophageal Squamous Cell Carcinoma* / surgery
  • Humans
  • Retrospective Studies
  • Treatment Outcome